
Joshua R Friedman MD PhD
Senior Vice President, Clinical Development
Join to View Full Profile
20 Llanfair CirArdmore, PA 19003
Dr. Friedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joshua Friedman is a specialist in Pediatric Gastroenterology based in Ardmore, PA. He completed his MD at the Perelman School of Medicine at the University of Pennsylvania and holds a PhD in Cellular and Molecular Biology from the same institution. His training includes a fellowship, residency, and internship in Pediatrics at the Children's Hospital of Philadelphia. Dr. Friedman is currently the Senior Vice President at Spyre Therapeutics. His research, particularly in inflammatory bowel diseases, is well-documented with multiple publications in reputable journals, including contributions to understanding disease activity and biomarker identification.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Gastroenterology, 2001 - 2004
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1998 - 2001
Children's Hospital of PhiladelphiaInternship, Pediatrics, 1998 - 1999
Perelman School of Medicine at the University of PennsylvaniaClass of 1998, MD
University of Pennsylvania School of MedicinePhD, Cellular and Molecular Biology, 1991 - 1996
Certifications & Licensure
PA State Medical License 2000 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Gastroenterology
Publications & Presentations
PubMed
- 24 citationsDeep Learning Models Capture Histological Disease Activity in Crohn's Disease and Ulcerative Colitis with High Fidelity.Dawid Rymarczyk, Weiwei Schultz, Adriana Borowa, Joshua R Friedman, Tomasz Danel
Journal of Crohn's & Colitis. 2024-04-23 - 77 citationsBiopsy and blood-based molecular biomarker of inflammation in IBD.Carmen Argmann, Ruixue Hou, Ryan C Ungaro, Haritz Irizar, Zainab Al-Taie
Gut. 2023-07-01 - 8 citationsA temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patients.Lauren A Peters, Joshua R Friedman, Aleksandar Stojmirovic, Jacob Hagen, Sander Houten
Communications Biology. 2023-01-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









